Write your message

Search published articles


Showing 3 results for Respiratory Distress

Fariba Almassinokiani, Maryam Sabouteh, Fahimeh Soheilipour, Maryam Kashanian, Peyman Akbari, Nahid Rahimzadeh,
Volume 2, Issue 3 (7-2016)
Abstract

Background and Objective: Preterm birth is a public health problem and late preterm birth (deliveries between
34-36 weeks of gestation) accounts for 75% of all preterm births. Antenatal Betamethasone can reduce
the severity of respiratory distress in preterm infants and its effect is accepted in 24-34 weeks of gestation. Our
goal was to determine the neonatal outcomes of Betamethasone prescription in late preterm births.
Methods: In a prospective cohort study in a tertiary teaching hospital, women at 34-36 weeks of gestation
and at risk for imminent preterm delivery took one course of Betamethasone arbitrarily according to the on-call
physician order (Betamethasone group) and the rate of neonatal respiratory distress and NICU admissions was
assessed. Also, we compared the results with the results of late preterm deliveries without taken antenatal Betamethasone
(Control group).
Results: We had 213 patients in control group and 187 in Betamethasone group. There was a significant difference
between results, in two groups in 34 and 35 weeks deliveries. Frequency of need to respiratory support
in Control group was 33.3% and in Betamethasone group was 9.6%. NICU admission in control group was
33.8% and in Betamethasone group was 10.7% (p=0.00).
Conclusion: In 34 and 35 weeks of gestation, one antenatal Betamethasone course, even a single dose of Betamethasone
has a significant effect on reduction of the respiratory distress and NICU admission rate.


Nasrin Hoseiny Nejad, Mahdie Niknezhadkhasmakhi,
Volume 4, Issue 2 (5-2018)
Abstract


Children interstitial lung (ChILD) disease is a large group of disorders with damage in alveolus and capillary. Although these disorders resemble ILD of adult in nomination, ChILD represents different pathologic and clinical patterns.
A 2.5 months old girl, with failure to thrive and grunting and dyspnea, complained of staccato coughs without association with feeding, since she was 15 days old and FTT.The patient appeared ill on admission, with central cyanosis, respiratory distress and hypoxemia (SpO2: 80%).she was admitted in PICU, and empirical antibiotic therapy was started, She was intubated.The chest radiography showed haziness in upper zone and parahilar of both lungs and left retro cardiac region. Barium swallow and bronchoscopy were normal. Echocardiography was normal. Chest CT scan showed haziness in posterior zone of bilateral lower lobes, and compensatory hyper aeration of upper lobe of right lung.
The patient was undergone the lung biopsy which included nonspecific interstitial pneumonia fibrotic variant which was most compatible with Interstitial Lung Disease.
 
Prof Fariba Almassinokiani, Prof Maryam Sabouteh, Prof Fahimeh Soheilipour, Prof Maryam Kashanian, Dr Peyman Akbari, Prof Nahid Rahimzadeh,
Volume 5, Issue 2 (11-2019)
Abstract

Introduction: Preterm birth is a public health problem and late preterm birth (deliveries between 34-36 weeks of gestation) accounts for 75% of all preterm births. Antenatal Betamethasone can reduce the severity of respiratory distress in preterm infants and its effect is accepted in 24-34 weeks of gestation. Our goal was to determine the neonatal outcomes of Betamethasone prescription in late preterm births.

Materials and methods: In a prospective cohort study in a tertiary teaching hospital, the women at 34-36 weeks of gestation and at risk for imminent preterm delivery took one course of Bethametasone arbitrarily according to the on-call physician order (Betamethasone group) and the rate of neonatal respiratory distress and NICU admissions was assessed, and we compared the results with the results of late preterm deliveries without taken antenatal Betamethasone (Control group).

Results: We had 213 patients in control group and 187 in Betamethasone group. There was a significant difference between results, in two groups in 34 and 35 weeks deliveries. Frequency of need to respiratory support in Control group was 33.3% and in Betamthasone group was 9.6%. NICU admission in Control group was 33.8% and in Betamethasone group was 10.7% (P=0.00).

Discussion and conclusion: In 34 and 35 weeks of gestation, one antenatal Betamethasone course, even a single dose of Betamethasone has a significant effect on reduction of the respiratory distress and NICU admission rate.



Page 1 from 1     

© 2025 CC BY-NC 4.0 | International Journal of Children and Adolescents

Designed & Developed by : Yektaweb